GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (OTCPK:BIESF) » Definitions » Shiller PE Ratio

Biotest AG (Biotest AG) Shiller PE Ratio : 169.33 (As of Jun. 08, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Biotest AG Shiller PE Ratio?

As of today (2024-06-08), Biotest AG's current share price is $30.48. Biotest AG's E10 for the quarter that ended in Mar. 2024 was $0.18. Biotest AG's Shiller PE Ratio for today is 169.33.

The historical rank and industry rank for Biotest AG's Shiller PE Ratio or its related term are showing as below:

BIESF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 27.09   Med: 69.47   Max: 1075
Current: 165.97

During the past years, Biotest AG's highest Shiller PE Ratio was 1075.00. The lowest was 27.09. And the median was 69.47.

BIESF's Shiller PE Ratio is ranked worse than
94.16% of 154 companies
in the Biotechnology industry
Industry Median: 30.475 vs BIESF: 165.97

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biotest AG's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.804. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.18 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biotest AG Shiller PE Ratio Historical Data

The historical data trend for Biotest AG's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Shiller PE Ratio Chart

Biotest AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.21 - 641.57 - 226.62

Biotest AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 379.11 226.62 169.98

Competitive Comparison of Biotest AG's Shiller PE Ratio

For the Biotechnology subindustry, Biotest AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotest AG's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biotest AG's Shiller PE Ratio falls into.



Biotest AG Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biotest AG's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=30.48/0.18
=169.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest AG's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Biotest AG's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.804/125.0381*125.0381
=0.804

Current CPI (Mar. 2024) = 125.0381.

Biotest AG Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.303 99.543 0.381
201409 0.176 99.823 0.220
201412 -0.016 99.543 -0.020
201503 0.040 99.717 0.050
201506 -0.101 100.417 -0.126
201509 -2.435 100.417 -3.032
201512 0.131 99.717 0.164
201603 0.056 100.017 0.070
201606 0.157 100.717 0.195
201609 -0.258 101.017 -0.319
201612 -1.192 101.217 -1.473
201703 -0.663 101.417 -0.817
201706 0.169 102.117 0.207
201709 -0.143 102.717 -0.174
201712 0.550 102.617 0.670
201803 0.826 102.917 1.004
201806 4.685 104.017 5.632
201809 0.152 104.718 0.181
201812 -0.276 104.217 -0.331
201903 -0.045 104.217 -0.054
201906 0.079 105.718 0.093
201909 -0.143 106.018 -0.169
201912 -0.062 105.818 -0.073
202003 -0.309 105.718 -0.365
202006 -0.180 106.618 -0.211
202009 -0.459 105.818 -0.542
202012 0.000 105.518 0.000
202103 -0.440 107.518 -0.512
202106 -0.133 108.486 -0.153
202109 -0.306 109.435 -0.350
202112 -1.014 110.384 -1.149
202203 -0.143 113.968 -0.157
202206 -0.412 115.760 -0.445
202209 -0.366 118.818 -0.385
202212 0.056 119.345 0.059
202303 -0.567 122.402 -0.579
202306 0.596 123.140 0.605
202309 3.085 124.195 3.106
202312 1.064 123.773 1.075
202403 0.804 125.038 0.804

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biotest AG  (OTCPK:BIESF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Biotest AG Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Biotest AG's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotest AG (Biotest AG) Business Description

Traded in Other Exchanges
Address
Landsteinerstrasse 5, Dreieich, DEU, 63303
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.

Biotest AG (Biotest AG) Headlines

From GuruFocus

Nine Months 2019 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Full Year 2019 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q3 2021 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q4 2020 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q4 2021 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q3 2022 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q4 2022 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Nine Months 2020 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024